Molecular and cellular mechanisms underlying the carcinogenicity and nephrotoxicity of aristolochic acid: hallmarks of a global environmental disease
马兜铃酸致癌性和肾毒性的分子和细胞机制:全球环境疾病的标志
基本信息
- 批准号:10005592
- 负责人:
- 金额:$ 27.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-16 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffinityAristolochiaAristolochic AcidsAsiansBindingBinding ProteinsBiochemicalBloodCarcinogensCell DeathCell FractionChemicalsChinaChronic Kidney FailureComplexConsumptionCountryDNADNA AdductsDataDiagnosisDiseaseDrug KineticsEarly DiagnosisEpidemiologyEuropeEventExposure toFemaleGenesGeneticGenomic DNAGoalsHalf-LifeHepatic TissueHerbHerbal supplementHumanIncidenceIndividualIngestionInjuryInternetIntrahepatic CholangiocarcinomaKidneyKidney DiseasesKineticsKnowledgeLaboratoriesLightLinkLiverMalignant NeoplasmsMalignant neoplasm of urinary bladderMeasuresMetabolic PathwayMetabolismMolecularMolecular ToxicologyMonitorMonoclonal AntibodiesMorbidity - disease rateMouse StrainsMusMutationPathway interactionsPlantsPlasmaPredispositionPreventionPrimary carcinoma of the liver cellsProgram Research Project GrantsPropertyProteinsProteomicsProximal Kidney TubulesPublic HealthRenal Cell CarcinomaRenal TissueResearchResearch DesignResistanceRiskRoleSeriesSerum AlbuminSliceSurface Plasmon ResonanceTaiwanTechniquesTimeTissuesToxic effectTranslational ResearchTubular formationUnited StatesUrinary tractUrineUrologic CancerXenobioticsadductanalogcancer diagnosiscarcinogenesiscarcinogenicitycytotoxicitydesigndetoxicationexperienceexperimental studygenotoxicityglobal environmentglobal healthhuman tissuemalemortalitymouse modelnephrotoxicitynovelorgan on a chippreventprogramsresistant strainresponsesuccesssulfotransferaseuptake
项目摘要
Aristolochic acid (AA) is a naturally occurring compound found only in Aristolochia plants. Although Aristolochia
species have long been used for medicinal purposes, their carcinogenic and nephrotoxic properties were
recognized only recently. Significant amounts of AA are present in herbal supplements marketed through the
Internet. And, in China and other Asian countries, where herbal remedies are widely used, 100 million people
are estimated to be at risk of developing aristolochic acid nephropathy (AAN), a devastating and uniformly fatal
disease. Importantly, AA’s unique mutational signature has clearly demonstrated its worldwide association with
upper urothelial tract cancers, bladder cancer, renal cell carcinoma, hepatocellular carcinoma and intrahepatic
cholangiocarcinoma. In this research, we use a multipronged approach to solve a complex global health problem.
Thus, we propose to identify mechanisms of AA-induced carcinogenicity and nephrotoxicity, important causes
of morbidity and mortality worldwide.
Our guiding hypothesis is that genes involved in bioactivation and inactivation of AA, and its transport to
target tissues, act both independently and together to determine individual susceptibility to AA’s toxic effects.
Using an integrated human liver-kidney-on-a-chip, we have recently demonstrated that AA activation occurs
primarily in the liver. Activated, chemically labile AA metabolites bind tightly to serum albumin and subsequently
are transported to the kidney, where they form covalent adducts with proteins and DNA. In Aim 1, we establish
pathways of AA metabolism, monitor the pharmacokinetics of AA, and quantify the distribution of AA metabolites,
aristolactam (AL)-DNA adducts, and AL-protein adducts among the blood, urine, and target tissues of sensitive
and resistant strains of mice. In Aim 2, we extend our human “organs-on-a-chip” studies and apply mass
spectrometric, fluorometric, and plasmon resonance techniques to illuminate the critical role of serum albumin
in protecting and transporting activated species of AA. However, although the genotoxic properties of AA account
for its carcinogenic effects, the molecular mechanisms of its nephrotoxicity are unknown. We hypothesize that
selective binding of AA to proteins in the renal proximal tubule initiates the cytotoxicity underlying AA’s
nephrotoxic effects. Thus, in Aim 3, we use novel proteomic techniques, affinity probes, and monoclonal
antibodies to explore nephrotoxic events, with the goal of identifying the specific renal tubular proteins involved.
Successful completion of this research program will advance significantly our knowledge of mechanisms involved
in the dual toxicities of AA. Also, data obtained in this study may provide a basis for establishing individual
susceptibility to AA, and will facilitate early diagnosis, prevention, and treatment of AA-induced cancers and
chronic renal disease. Given the worldwide exposure to AA, this research has significant implications for global
public health. Additionally, the techniques perfected in the three aims of this project will serve as templates for
investigating other causes of nephrotoxicity and carcinogenicity.
马兜铃酸(AA)是一种天然存在的化合物,只存在于马兜铃属植物中。虽然马兜铃
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Viktoriya S Sidorenko其他文献
Viktoriya S Sidorenko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Viktoriya S Sidorenko', 18)}}的其他基金
Mechanisms underlying activation and detoxification of aristolochic acids in human hepatic and renal cells
马兜铃酸在人肝肾细胞中的激活和解毒机制
- 批准号:
10190228 - 财政年份:2021
- 资助金额:
$ 27.91万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 27.91万 - 项目类别:
Continuing Grant